Practical aspects of intensive insulinization in the intensive care unit

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 2, 2007, Pages 197-205

  Boulkina, Lioubov S ^a   Braithwaite, Susan S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Dept of Endocrinol and Metabolism   (United States)

Author keywords

Algorithms; Critical care; Hyperglycemia; Insulin; Insulin infusion systems; Intensive care

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; BURN; CLINICAL PROTOCOL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; ENTERIC FEEDING; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEART INFARCTION; HEART SURGERY; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE; MONOTHERAPY; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION; POSTOPERATIVE INFECTION; REVIEW; RISK FACTOR; SEPSIS; STROKE; TREATMENT OUTCOME;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; POINT-OF-CARE SYSTEMS;

EID: 33846870139     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3280141ff4     Document Type: Review

References (126)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366.
3. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65.
4. Malmberg K, Ryden L, Hamstent A, et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. Eur Heart J 1996; 17:1337-1344.
5. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314:1512-1515.
6. Zerr KJ, Furnary AP, Grunkemeier GL. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-361.
7. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-362.
8. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27:553-591.
9. American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control. Endocr Pract 2004; 10(Suppl 2): 4-12.
10. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006; 29(Suppl 1): S4-S42.
11. Krinsley JS. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Mayo Clin Proc 2003; 78:1471-1478.
12. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10 (Suppl 2): 46-52.
13. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109:1497-1502.
14. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000.
15. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 129:644-650.
16. Gentile NT, Seftchick MW, Huynh T, et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13:174-180.
17. Nasraway SA Jr. Hyperglycemia During Critical Illness. JPEN J Parenter Enteral Nutr 2006; 30:254-258.
18. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 2006; 131:34-42.
19. Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141:375-380.
20. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006; 15:370-377.
21. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047.
22. Inzucchi SE, Rosenstock J. Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 2005; 28:976-979.
23. Freire AX, Bridges L, Umpierrez GE, et al. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005; 128:3109-3116.
24. Brunkhorst FM, Kuhnt E, Engel C. Intensive insulin therapy in patients with severe sepsis and septic shock is associated with an increased rate of hypoglycemia: results from a randomized multicenter study (VISEP). Infection 2005; 33:19-20.
25. Bhatia A, Cadman B, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg 2006; 102:549-551.
26. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
27. Watkinson P, Barber VS, Young JD. Strict glucose control in the critically ill. BMJ 2006; 332:865-866.
28. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164:2005-2011.
29. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2006; 30:164-172.
30. Braithwaite SS, Godara H, Song H-J, Rock P. No patient left behind: evaluation and design of intravenous insulin infusion algorithms. Endocr Pract 2006; 12 (Suppl 3):72-78.
31. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. N Engl J Med 1986; 315:1245-1250.
32. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract 2004; 10 (Suppl 2):71-80.
33. Vriesendorp TM, Van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101.
34. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007, in press.
35. The ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control: a call to action. Diabetes Care 2006; 29:1955-1962.
36. Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf 2005; 31:141-147.
37. Lien LF, Spratt SE, Zinta Woods Z, et al. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract 2005; 11:240-253.
38. Davis ED, Harwood K, Midgett L, et al. Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. Diabetes Educ 2005; 31:818-823.
39. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for diabetic patients undergoing heart surgery. Endocr Pract 2002; 8:10-18.
40. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003; 88:2430-2437.
41. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004; 10 (Suppl 2):71-80.
42. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467.
43. Goldberg PA, Roussel MG, Inzucchi SE. Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectr 2005; 18:188-191.
44. Vora AC, Saleem TM, Polomano RC, et al. Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes. Endocr Pract 2004;10:112-118.
45. Rood E, Bosman RJ, Van der Spoel JI, et al. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc 2005; 12:172-180.
46. Bland DK, Fankhanel Y, Langford E, et al. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care 2005; 14:370-376.
47. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120 618 h of operation. Diabetes Care 2005; 28:2418-2423.
48. Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak 2005; 5:38.
49. Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006; 29:271-276. Performance of a model predictive control algorithm is described, having a glucoregulatory model with individual parameters that are adapted on-line; using glucose concentration, insulin dosage, and carbohydrate intake as input variables; having a dose optimizer that proposes future insulin infusion rates and tunes the rates until the predicted glucose excursion fits into the desired glucose excursion; and having eventual potential to be used in conjunction with the actual carbohydrate and insulin delivery system.
50. Braithwaite SS, Edkins R, MacGregor KL, et al. Performance of a dosedefining insulin infusion protocol among trauma service ICU admissions. Diabetes Technol Ther 2006; 8:476-488. Together with data on glycemic variability within-run and between runs, a tabular column-based protocol is described in which each column is identified with a maintenance requirement for insulin infusion, assigning exponentially ascending rates from 0.1 units/h to the maintenance rate between BG 70 mg/dl and the upper target, with an infusion rate equal to maintenance rate at the upper target, and with increasing infusion rates above the upper target linearly related to the column maintenance rate and to the BG increment above the target.
51. Lonergan T, Le Compte A, Willacy M, et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther 2006; 8:191-206.
52. Lonergan T, Compte AL, Willacy M, et al. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol Ther 2006;:449-462. An insulin wheel is described that manually matches carbohydrate exposure and observed changes of blood glucose to desired insulin bolus amounts precalculated under a control algorithm.
53. Osburne RC, Cook CB, Stockton L, et al. Improving hyperglycemia management in the intensive care unit: preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. Diabetes Educ 2006; 32:394-403. Use of a nurse-driven tabular column-based paper protocol with an algorithm related to Glucommander is described.
54. Button E, Keaton P. Glycemic control after coronary bypass graft: using intravenous insulin regulated by a computerized system. Crit Care Nurs Clin North Am 2006; 18:257-265; xi.
55. Taylor BE, Schallom ME, Sona CS, et al. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg 2006; 202:1-9. Physician-directed intravenous insulin infusion without a developed protocol compared unfavorably with protocolized nurse-driven intravenous insulin infusion.
56. cross step next estimate' (abstract). In: Diabetes Technology Society Meeting Abstracts. Atlanta: Diabetes Technology Society, 2-4 November, 2006, A50. Calculation of the maintenance rate cross step next estimate is proposed as a strategy during correction of hyperglycemia which, by leading to discovery of the maintenance requirement, may reduce time to target and reduce the amplitude of subsequent glycemic oscillations.
57. Piper HG, Alexander JL, Shukla A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics 2006; 118:1176-1184.
58. Braithwaite SS. Twilight of the sliding scale. The Hospitalist 2006; 10:24-26.
59. Schoeffler JM, Rice DAK, Gresham DG. 70/30 insulin algorithm versus sliding scale insulin. Ann Pharmacother 2005; 39:1606-1609.
60. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005; 28:1008-1011.
61. Baldwin D, Boord J, Braithwaite S, et al. The University HealthSystem Consortium (UHC) Benchmarking Project: evaluation of hospital glycemic control at academic medical centers (AMC) (abstract 437-P). Diabetes 2006; 55 (Suppl 1):A104.
62. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-1021.
63. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland diabetic project. Endocr Pract 2004; 10 (Suppl 2):21-33.
64. Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract 2004; 10 (Suppl 2): 81-88.
65. Campbell KB, Braithwaite SS. Hospital management of hyperglycemia. Clin Diabetes 2004; 22:81-88.
66. Thompson CL, Dunn KC, Menon MC, et al. Hyperglycemia in the hospital. Diabetes Spectr 2005; 18:20-27.
67. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006; 98:557-564.
68. Leahy JL. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract 2006; 12 (Suppl 3):86-90.
69. Burroughs V, Weinberger J. Diabetes and stroke: part two - treating diabetes and stress hyperglycemia in hospitalized stroke patients. Curr Cardiol Rep 2006; 8:29-32.
70. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract 2006; 12 (Suppl 3): 22-26. An updated summary of results of the long-running Portland project is presented, describing progressively lower mean 3-day BG accompanied by mortality reduction for patients with diabetes, under a care plan that emphasizes intensive insulin treatment for the first 3 days after heart surgery.
71. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.
72. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446.
73. Hirsch IB. Inpatient diabetes: review of data from the cardiac care unit. Endocr Pract 2006; 12 (Suppl 3):27-34.
74. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151-3159.
75. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2002; 74:712-719.
76. McAlister FA, Man J, Bistritz L, et al. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 2003; 26:1518-1524.
77. Lazar HL, Chipkin S, Philippides G, et al. Glucose-insulin- potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000; 70:145-150.
78. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80:862-866.
79. Cely CM, Arora P, Quartin AA, et al. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004; 126:879-887.
80. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56:1058-1062.
81. Sung J, Bochicchio GV, Joshi M, et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80-83.
82. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long term insulin infusion in severely burned patients. Ann Surg 1995; 222:283-297.
83. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145:4084-4093.
84. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544.
85. Sugita H, Kaneki M, Sugita M, et al. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 2005;288:E585-E591.
86. Rosenberg SA, Brief DK, Kinney JM, et al. The syndrome of dehydration, coma and severe hyperglycemia without ketosis in patients convalescing from burns. New Engl J Med 1965; 272:931-938.
87. Wilmore DW, Mason AD Jr, Pruitt BA. Insulin response to glucose in hypermetabolic burn patients. Ann Surg 1976; 183:314-320.
88. Lee JO, Benjamin D, Herndon DN. Nutrition support strategies for severely burned patients. Nutr Clin Pract 2005; 20:325-330.
89. Molavi A, Andrews K, Milner S, et al. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg 2000; 45:629-632.
90. Gore DC, Chinkes DL, Hart DW, et al. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002; 30:2438-2442.
91. Pham TN, Warren AJ, Phan HH, et al. Impact of tight glycemic control in severely burned children. J Trauma 2005; 59:1148-1154.
92. Wolak ES, Moretz DA, Byerly F, et al. Perception versus reality: nurse utilization of insulin drip protocols in the burn intensive care unit. Presented at Southern Medical Association 19th Annual Region Conference. Nashville, November, 2005.
93. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22:77-81.
94. Vriesendorp TM, Morelis QJ, DeVries JH, et al. Early postoperative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004; 5:520-525.
95. Golden SH, Peart-Vigilance C, Kao WHL, Brancati F. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22:1408-1414.
96. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607-612.
97. Najarian J, Swavely D, Wilson E, et al. Improving outcomes for diabetic patients undergoing vascular surgery. Diabetes Spectr 2005; 18:53-60.
98. Thomas M, Mathew T, Russ G, et al. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation 2001; 72:1321-1324.
99. Thomas MC, Moran J, Mathew TH, et al. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrology 2000; 1:1.
100. Melin J, Hellberg L, Larsson E, et al. Protective effect of insulin on ischemic renal injury in diabetes mellitus. Kidney Int 2002; 61:1383-1392.
101. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34:2208-2214.
102. Capes S, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nodiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426-2432.
103. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-674.
104. Gentile, Blood glucose control after acute stroke: a retrospective study. Acad Emerg Med 2003; 10:432.
105. Levetan CS. Effect of hyperglycemia on stroke outcomes. Endocr Pract 2004; 10 (Suppl 2):34-39.
106. Leigh R, Zaidat OO, Suri MF, et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004; 35:1903-1907.
107. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 2004; 35:363-364.
108. Gentile NT, Seftchick MW, Huynh T, et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13:174-180.
109. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29:765-770.
110. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778.
111. Bolk J, Van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207-214.
112. Foo K, Cooper J, Deaner A, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89:512-516.
113. Schnell O, Schafer O, Kleybrink S, et al. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 2004; 27:455-460.
114. Stranders I, Diamant M, Van Gelder RE, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-988.
115. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632.
116. Meier JJ, Deifuss S, Klamann A, et al. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 2005; 28:2551-2553.
117. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111:3078-3086.
118. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27:1289-1297.
119. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26:1255-1261.
120. Pinto DS, Skolnick AH, Kirtane AJ, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 46:178-180.
121. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006; 166:1613-1619.
122. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109:1745-1749.
123. Weiser M. Relation between the duration of remission and hyperglycemia in induction chemotherapy for acute lymphocytic leukemia. Cancer 2004; 100:1179-1185.
124. Falguera M, Pifarre R, Martin A, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005; 128:3233-3239.
125. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61:284-289.
126. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684.